Merrimack Pharmaceuticals
MACK
#7939
Rank
HK$1.73 B
Marketcap
HK$117.44
Share price
0.00%
Change (1 day)
1.83%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -HK$0.86

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$0.85. In 2022 the company made an earnings per share (EPS) of -HK$0.85 an increase over its 2021 EPS that were of -HK$1.40.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$0.860.96%
2022-HK$0.85-38.89%
2021-HK$1.40-25%
2020-HK$1.86-81.54%
2019-HK$10.09-56.95%
2018-HK$23.44-108.5%
2017HK$275.64-390.35%
2016-HK$94.93-7.35%
2015-HK$102.4665%
2014-HK$62.10-39.39%
2013-HK$102.46-54.01%
2012-HK$222.78-53.71%
2011-HK$481.2940.37%
2010-HK$342.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$24.69-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-HK$6.52 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.64 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$14.67 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$43.78 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA